FDA Won't Even Review mRNA Flu Vaccine Application

Moderna just got an unusually cold shoulder from the FDA over its latest vaccine push, the New York Times reports. The company says regulators have refused to even review its application for an experimental mRNA flu shot, issuing a rare "refuse to file" letter that short-circuits the normal, months-long evaluation...